BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

815 related articles for article (PubMed ID: 20368541)

  • 21. Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level.
    Chen CJ; Yang HI; Su J; Jen CL; You SL; Lu SN; Huang GT; Iloeje UH;
    JAMA; 2006 Jan; 295(1):65-73. PubMed ID: 16391218
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Viral level is an indicator of long-term outcome of hepatitis B virus e antigen-negative carriers with persistently normal serum alanine aminotransferase levels.
    Nakazawa T; Shibuya A; Takeuchi A; Shibata Y; Hidaka H; Okuwaki Y; Takada J; Tanaka Y; Watanabe M; Minamino T; Sakurai K; Koizumi W
    J Viral Hepat; 2011 Jul; 18(7):e191-9. PubMed ID: 21692932
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepatitis C virus seromarkers and subsequent risk of hepatocellular carcinoma: long-term predictors from a community-based cohort study.
    Lee MH; Yang HI; Lu SN; Jen CL; Yeh SH; Liu CJ; Chen PJ; You SL; Wang LY; Chen WJ; Chen CJ
    J Clin Oncol; 2010 Oct; 28(30):4587-93. PubMed ID: 20855826
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Chronic hepatitis B virus (HBV) infection: usefulness of the combination of HBeAg and ALT determination to predict a high HBV-DNA level and therefore the necessity of referral to a specialist for possible antiviral treatment].
    Veldhuijzen IK; Mostert MC; Niesters HG; Richardus JH; de Man RA
    Ned Tijdschr Geneeskd; 2008 Jun; 152(25):1426-30. PubMed ID: 18624006
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pre-S deletion and complex mutations of hepatitis B virus related to advanced liver disease in HBeAg-negative patients.
    Chen CH; Hung CH; Lee CM; Hu TH; Wang JH; Wang JC; Lu SN; Changchien CS
    Gastroenterology; 2007 Nov; 133(5):1466-74. PubMed ID: 17915220
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Subgenotypes of hepatitis B virus genotype C do not correlate with disease progression of chronic hepatitis B in Taiwan.
    Tseng TC; Liu CJ; Chen PJ; Lai MY; Lin CL; Kao JH; Chen DS
    Liver Int; 2007 Sep; 27(7):983-8. PubMed ID: 17696938
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lower serum viral loads in young patients with hepatitis-B-virus-related hepatocellular carcinoma.
    Tsai FC; Liu CJ; Chen CL; Chen PJ; Lai MY; Kao JH; Chen DS
    J Viral Hepat; 2007 Mar; 14(3):153-60. PubMed ID: 17305880
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Independent risk factors and predictive score for the development of hepatocellular carcinoma in chronic hepatitis B.
    Yuen MF; Tanaka Y; Fong DY; Fung J; Wong DK; Yuen JC; But DY; Chan AO; Wong BC; Mizokami M; Lai CL
    J Hepatol; 2009 Jan; 50(1):80-8. PubMed ID: 18977053
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Predictive factors for early HBeAg seroconversion in acute exacerbation of patients with HBeAg-positive chronic hepatitis B.
    Kim HS; Kim HJ; Shin WG; Kim KH; Lee JH; Kim HY; Jang MK
    Gastroenterology; 2009 Feb; 136(2):505-12. PubMed ID: 19101558
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical factors associated with liver stiffness in hepatitis B e antigen-positive chronic hepatitis B patients.
    Wong GL; Wong VW; Choi PC; Chan AW; Chim AM; Yiu KK; Chan HY; Chan FK; Sung JJ; Chan HL
    Clin Gastroenterol Hepatol; 2009 Feb; 7(2):227-33. PubMed ID: 19121647
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of hepatitis B viral load and basal core promoter mutation in hepatocellular carcinoma in hepatitis B carriers.
    Liu CJ; Chen BF; Chen PJ; Lai MY; Huang WL; Kao JH; Chen DS
    J Infect Dis; 2006 May; 193(9):1258-65. PubMed ID: 16586363
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of serial measurement of serum HBV DNA levels in patients with chronic HBeAg(-) hepatitis B infection: association with liver disease progression. A prospective cohort study.
    Zacharakis G; Koskinas J; Kotsiou S; Tzara F; Vafeiadis N; Papoutselis M; Maltezos E; Sivridis E; Papoutselis K
    J Hepatol; 2008 Dec; 49(6):884-91. PubMed ID: 18674840
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Longitudinal changes in serum HBV DNA levels and predictors of progression during the natural course of HBeAg-negative chronic hepatitis B virus infection.
    Papatheodoridis GV; Chrysanthos N; Hadziyannis E; Cholongitas E; Manesis EK
    J Viral Hepat; 2008 Jun; 15(6):434-41. PubMed ID: 18194171
    [TBL] [Abstract][Full Text] [Related]  

  • 34. e-antigen-negative chronic hepatitis B in Bangladesh.
    Ahmad N; Alam S; Mustafa G; Adnan AB; Baig RH; Khan M
    Hepatobiliary Pancreat Dis Int; 2008 Aug; 7(4):379-82. PubMed ID: 18693173
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of occult hepatitis B virus infection and prior hepatitis B virus infection on development of hepatocellular carcinoma in patients with liver cirrhosis due to hepatitis C virus.
    Adachi S; Shibuya A; Miura Y; Takeuchi A; Nakazawa T; Saigenji K
    Scand J Gastroenterol; 2008; 43(7):849-56. PubMed ID: 18584524
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of viral kinetics in patients with hepatitis B e antigen-positive chronic hepatitis B.
    Wu IC; Chow NH; Cheng PN; Liu WC; Young KC; Chang WL; Chen CY; Tseng KC; Chang TT
    J Med Virol; 2007 Jun; 79(6):663-9. PubMed ID: 17457902
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Determinants of spontaneous surface antigen loss in hepatitis B e antigen-negative patients with a low viral load.
    Tseng TC; Liu CJ; Yang HC; Su TH; Wang CC; Chen CL; Kuo SF; Liu CH; Chen PJ; Chen DS; Kao JH
    Hepatology; 2012 Jan; 55(1):68-76. PubMed ID: 21858846
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influence of viral load and genotype in the progression of Hepatitis B-associated liver cirrhosis to hepatocellular carcinoma.
    Mahmood S; Niiyama G; Kamei A; Izumi A; Nakata K; Ikeda H; Suehiro M; Kawanaka M; Togawa K; Yamada G
    Liver Int; 2005 Apr; 25(2):220-5. PubMed ID: 15780042
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum hepatitis B surface antigen levels predict surface antigen loss in hepatitis B e antigen seroconverters.
    Tseng TC; Liu CJ; Su TH; Wang CC; Chen CL; Chen PJ; Chen DS; Kao JH
    Gastroenterology; 2011 Aug; 141(2):517-25, 525.e1-2. PubMed ID: 21672542
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Positive serum hepatitis B e antigen is associated with higher risk of early recurrence and poorer survival in patients after curative resection of hepatitis B-related hepatocellular carcinoma.
    Sun HC; Zhang W; Qin LX; Zhang BH; Ye QH; Wang L; Ren N; Zhuang PY; Zhu XD; Fan J; Tang ZY
    J Hepatol; 2007 Nov; 47(5):684-90. PubMed ID: 17854945
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 41.